Mohamed Elsharkawy

Koru Pharma Co., Ltd.

Koru Pharma Co., Ltd. is a global biopharmaceutical company founded in 2016 specializing in medical aesthetic products for anti-ageing and skin rejuvenation. Today, the company is deeply committed to providing innovative cosmetological solutions that meet the highest standards of safety and efficacy while satisfying the needs of patients and practitioners. In a short time Koru Pharmaceuticals has become one of the major players in the Medical Aesthetics market with a global network of distributors and an extensive product portfolio available in more than 80 countries. We are committed to developing, manufacturing and commercializing innovation and pioneering medical solutions for corrective and aesthetic applications in dedication to humanity's quest for happier, more beautiful and quality lives. Koru Pharmaceuticals' global strategies are focused on the key principles of internal product development, strategic partnerships and select mergers/acquisitions of products, technologies and companies. We are committed to identifying opportunities that fit our capabilities, enhance our corporate goals and strengthen our competitive position as we expand our global pharmaceutical business. Global Presence & Distribution Network: Production & Supply: Seoul, South Korea Sales & Marketing: Kuala Lumpur, Malaysia R&D Laboratory: Seoul, South Korea and San Francisco, USA Manufacturing facility: Chuncheon, South Korea Logistics Center: Kyvi, Ukraine and Guangzhou, China Exports: 6 continents; 80+ countries At A Glance The company has shown tremendous and continuous growth since its establishment. From its headquarters in Seoul, South Korea, Koru Pharmaceuticals has made its mark across the globe. A team of over 60 working tirelessly to generate approximately US$ 24 million in sales in 2022 from over 200 products. Product Portfolio: Anaesthetics, Biorevitalization, Chemical Peelings, Cosmeceuticals, Fillers, Lipolytics, Microneedling, Placenta Injections, Threads